AP337A - Salts of substituted quinoline compounds and their use as inhibitors of gastric acid secretion. - Google Patents
Salts of substituted quinoline compounds and their use as inhibitors of gastric acid secretion. Download PDFInfo
- Publication number
- AP337A AP337A APAP/P/1992/000352A AP9200352A AP337A AP 337 A AP337 A AP 337A AP 9200352 A AP9200352 A AP 9200352A AP 337 A AP337 A AP 337A
- Authority
- AP
- ARIPO
- Prior art keywords
- salts
- inhibitors
- salt
- gastric acid
- acid secretion
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919101918A GB9101918D0 (en) | 1991-01-29 | 1991-01-29 | Compound |
| GB919101919A GB9101919D0 (en) | 1991-01-29 | 1991-01-29 | Compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AP9200352A0 AP9200352A0 (en) | 1992-01-31 |
| AP337A true AP337A (en) | 1994-04-08 |
Family
ID=26298350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| APAP/P/1992/000352A AP337A (en) | 1991-01-29 | 1992-01-27 | Salts of substituted quinoline compounds and their use as inhibitors of gastric acid secretion. |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0569396A1 (es) |
| JP (1) | JPH06504541A (es) |
| CN (1) | CN1064268A (es) |
| AP (1) | AP337A (es) |
| AU (1) | AU652028B2 (es) |
| CA (1) | CA2099117A1 (es) |
| CZ (1) | CZ153293A3 (es) |
| FI (1) | FI933376A (es) |
| HU (1) | HUT67609A (es) |
| IE (1) | IE920267A1 (es) |
| IL (1) | IL100791A0 (es) |
| MA (1) | MA22401A1 (es) |
| MX (1) | MX9200338A (es) |
| NO (1) | NO932722D0 (es) |
| NZ (1) | NZ241408A (es) |
| PT (1) | PT100056A (es) |
| SK (1) | SK70993A3 (es) |
| WO (1) | WO1992012969A1 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9126438D0 (en) * | 1991-12-12 | 1992-02-12 | Smithkline Beecham Intercredit | New quinoline derivatives |
| US5556863A (en) * | 1993-06-11 | 1996-09-17 | Astra Aktiebolag | Compound for gastric acid secretion inhibition |
| IS4164A (is) * | 1993-06-11 | 1994-12-12 | Ab Astra | Efnasambönd sem hindra flæði magasýru |
| USRE43932E1 (en) | 1997-07-18 | 2013-01-15 | Novartis Ag | Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| US6852739B1 (en) | 1999-02-26 | 2005-02-08 | Nitromed Inc. | Methods using proton pump inhibitors and nitric oxide donors |
| UA80393C2 (uk) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
| AU2002342917A1 (en) * | 2001-11-19 | 2003-06-10 | Altana Pharma Ag | Reversible proton pump inhibitors for the treatment of airway disorders |
| MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
| EP1534278A4 (en) | 2002-08-01 | 2006-09-06 | Nitromed Inc | NITROSED PROTONATE PUMP INHIBITORS, COMPOSITIONS AND USE METHOD |
| EP1682133A1 (en) | 2003-11-03 | 2006-07-26 | AstraZeneca AB | Imidazo 1,2-a pyridine derivatives for the treatment of silent gastro-esophageal reflux |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0330485A1 (en) * | 1988-02-25 | 1989-08-30 | SmithKline Beecham Intercredit B.V. | 4-Amino-3-acyl quinoline derivatives and their use as inhibitors of gastric acid secretion |
-
1992
- 1992-01-27 CA CA002099117A patent/CA2099117A1/en not_active Abandoned
- 1992-01-27 NZ NZ241408A patent/NZ241408A/en unknown
- 1992-01-27 WO PCT/EP1992/000200 patent/WO1992012969A1/en not_active Application Discontinuation
- 1992-01-27 SK SK709-93A patent/SK70993A3/sk unknown
- 1992-01-27 EP EP92903019A patent/EP0569396A1/en not_active Withdrawn
- 1992-01-27 MA MA22687A patent/MA22401A1/fr unknown
- 1992-01-27 CZ CZ931532A patent/CZ153293A3/cs unknown
- 1992-01-27 MX MX9200338A patent/MX9200338A/es unknown
- 1992-01-27 AP APAP/P/1992/000352A patent/AP337A/en active
- 1992-01-27 JP JP4503051A patent/JPH06504541A/ja active Pending
- 1992-01-27 AU AU11799/92A patent/AU652028B2/en not_active Ceased
- 1992-01-27 HU HU9302201A patent/HUT67609A/hu unknown
- 1992-01-28 IE IE026792A patent/IE920267A1/en unknown
- 1992-01-28 PT PT100056A patent/PT100056A/pt not_active Application Discontinuation
- 1992-01-28 CN CN92101029A patent/CN1064268A/zh active Pending
- 1992-01-28 IL IL100791A patent/IL100791A0/xx unknown
-
1993
- 1993-07-28 FI FI933376A patent/FI933376A/fi unknown
- 1993-07-28 NO NO932722A patent/NO932722D0/no unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0330485A1 (en) * | 1988-02-25 | 1989-08-30 | SmithKline Beecham Intercredit B.V. | 4-Amino-3-acyl quinoline derivatives and their use as inhibitors of gastric acid secretion |
Also Published As
| Publication number | Publication date |
|---|---|
| IL100791A0 (en) | 1992-09-06 |
| CZ153293A3 (en) | 1993-12-15 |
| WO1992012969A1 (en) | 1992-08-06 |
| IE920267A1 (en) | 1992-07-29 |
| CN1064268A (zh) | 1992-09-09 |
| FI933376A0 (fi) | 1993-07-28 |
| MA22401A1 (fr) | 1992-10-01 |
| AU652028B2 (en) | 1994-08-11 |
| AU1179992A (en) | 1992-08-27 |
| HUT67609A (en) | 1995-04-28 |
| PT100056A (pt) | 1993-03-31 |
| EP0569396A1 (en) | 1993-11-18 |
| HU9302201D0 (en) | 1993-10-28 |
| NO932722L (no) | 1993-07-28 |
| FI933376A (fi) | 1993-07-28 |
| CA2099117A1 (en) | 1992-07-30 |
| NZ241408A (en) | 1994-05-26 |
| AP9200352A0 (en) | 1992-01-31 |
| NO932722D0 (no) | 1993-07-28 |
| SK70993A3 (en) | 1994-01-12 |
| JPH06504541A (ja) | 1994-05-26 |
| MX9200338A (es) | 1992-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3447292B2 (ja) | イミダゾピリジン及び胃腸の疾病の治療のためのその使用 | |
| AP337A (en) | Salts of substituted quinoline compounds and their use as inhibitors of gastric acid secretion. | |
| KR20170017607A (ko) | RET 키나아제 저해제인 신규 3-(이속사졸-3-일)-피라졸로[3,4-d]피리미딘-4-아민 화합물 | |
| KR100704152B1 (ko) | ＮＦ-κＢ 저해제를 유효 성분으로 하는 심근염, 확장형 심근증 및 심부전의 예방제 또는 치료제 | |
| JP2502343B2 (ja) | 薬学的に活性な置換ベンズアミド | |
| US5045541A (en) | Fused pyridazine compounds and their pharmaceutical use | |
| EP1097924B1 (en) | 4-hydroxy-4-phenylpiperidine derivatives having opioid agonist activity and pharmaceuticals containing the same | |
| EP3216791A1 (en) | Polymorphic substance of yonkenafil hydrochloride, preparation method therefor, and composition and use thereof | |
| JP2974351B2 (ja) | プロドラッグとしての６―クロロ―７，８―ジヒドロキシ―１―（４’―ヒドロキシフェニル）―２，３，４，５―テトラヒドロ―１ｈ―３―ベンズアゼピンのカルバメート | |
| WO2023154338A1 (en) | Solid forms of a parp14 inhibitor | |
| KR20030043970A (ko) | 2,2-디페닐부탄아미드 유도체 및 이를 함유하는 의약 | |
| EP0146155B1 (en) | Ether of n-propanolamine derivative | |
| WO2021249324A1 (zh) | 烯基嘧啶类化合物、其制备方法与应用 | |
| JPH069402A (ja) | 抗潰瘍剤 | |
| WO1990004590A1 (en) | Benzothiadiazepine derivatives | |
| JPS6130588A (ja) | ベンゾ〔ｃ〕〔１，８〕ナフチリジン、その製造方法及びその使用、並びにこれらの化合物を含有する調製剤 | |
| JP3068175B2 (ja) | イソチアゾロ〔５，４―ｂ〕ピリジン誘導体 | |
| JP2760633B2 (ja) | 抗ヒスタミン剤 | |
| JPH0517442A (ja) | ピペリジン誘導体 | |
| JP2000038382A (ja) | 新規ベンゾフラノン誘導体及びその製造方法 | |
| KR20220050525A (ko) | 항암, 항염증 효능을 가진 삼원환의 약학적 조성물 | |
| JPH01216980A (ja) | アルキル―ピペラジニル―５，６―アルキレンピリミジン類 | |
| JPS60105652A (ja) | Ｎ‐（４‐アセチルアミノフエナシル）アミン誘導体およびこれを含む治療用組成物ならびにこの誘導体の製造方法 | |
| HUT77949A (hu) | Kinolinszármazékok, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| WO2008010794A1 (en) | Pharmaceutical preparations of crystalline lazabemide |